DND Technologies Inc (DNDT)

[gamood]

DNDT has a near perfect technical set-up. With a market cap of $44,463, a tiny float and a current PPS of just $.015 this play could provide BIG gains very fast! There is very little trading activity on this stock and it appears with increased awareness DNDT could quickly gain the attention of Wall Street.


The company has a wholly owned subsidiary that is ready to roll out a mobile wallet platform that will be used for everyday shopping in one of the worlds fastest growing economies!


About DNDT - DND Technologies

(Current PPS. $.015)

Founded in 1997, DND Technologies ( Symbol: DNDT) is a publicly traded holding company that acquires, invests in, or partners with next generation start-ups and established businesses to bring new or improved products to market.

DNDT’s core competencies include acquiring or taking strategic financial positions in cutting-edge companies that have synergies in business-to-business and business-to-consumer products, and new technology opportunities that are targeted to resolving unmet consumer needs and emergent business domains.

DNDT has already taken a number of strategic and financial positions in research and development activities in both on-going and start-up businesses. In most of these areas, basic research has been completed and DNDT is in the process of obtaining intellectual property rights. Announcements will be made here as soon as project-specific funds and/or strategic partnerships are secured.

One of the most intriguing aspects of DNDT is their wholly owned subsidiary of Cinutri, a mobile supermarket shopping and payment business solution platform that allows users to use their mobile phones to remotely purchase goods from supermarkets.

After the completion of a very promising consumer demand survey, using a proprietary mobile payments technology platform and working in concert with a large network of Brazilian supermarkets, DND Technologies is preparing to launch a mobile supermarket shopping pilot project named Cinutri as an independent, wholly-owned, subsidiary in Brazil.

DND Technologies management believes that this will be a great project with an excellent profit potential which will contribute greatly to shareholder value.

Cinutri allows users to use their mobile phones to remotely purchase goods from supermarkets, and have those goods delivered to their homes immediately or at some other requested time period. After registering for the service, users will be able to buy their required products with a few strokes on their mobile phones without the need to go to the supermarket. After registration, the consumer will receive a link via SMS to download the application on their phone, or they can download it from the Apple Store or the Android Play Store. Payments for purchased items will automatically be deducted from debit/credit cards and bank accounts programmed in during registration by the user.

Market Outlook

The total addressable market for multi-platform app development is worth US $ 2.4bn in 2013. Cross-platform tools help developers to deliver their multi-platform app development projects more efficiently. DNDT is at the forefront of this technology in one of the largest growing markets in the world!

The key factor to winning a share of the mobile wallet is customer experience. Consumers want an intuitive experience that is well thought out and provides engagement. To be successful, the mobile wallet must meet and exceed consumer expectations; otherwise, it will be quickly dismissed.

The global mobile wallet market is forecasted to reach $1,602.4 billion in five years, growing at a compound annual growth rate of 30.7 percent from 2012 to 2018.

DNDT has also acquired all the inventory, other assets and the exclusive rights to distribute a pharmaceutical line of products in the United States, Canada and Europe.

Rebranded by DNDT, the inventory of products includes Bioassaygen Gel, Bioassaygen Cosmetic Mask, Bioassaygen Bio-Skin, and Bioassaygen Delivery Gel, all of which will henceforth be manufactured and distributed by DNDT under the “Bioassaygen”. brand of products.

A contract-manufacturer for the product has already been identified in Europe, and sale and distribution arrangements are currently being made in several European countries.

Bioassaygen Gel, is a cosmeceutical that, when applied directly to the Skin, reduces wrinkles and promotes natural skin re-genesis.

Bioassaygen Cosmetic Mask is a stabilizing platform for the sustained use of Bioassaygen Gel. It is used mainly for vanity applications.


Bioassaygen Bio-Skin is a scientifically developed Skin Replacement Bandage.

Bioassaygen Delivery Gel (a serum) is a biologically-active catalyst that, when applied, creates an environment which accelerates natural skin re-genesis. Generally used in conjunction with Bioassaygen Bio-Skin.

The patented Skin Replacement Bandage and Delivery Gel products are designed to replace natural skin that may have been lost due to burns, frostbite, pressure sores, etc. The Bio-Skin technology is designed to replaces traditional skin grafting by using synthetically-created skin in lieu of natural skin.

DNDT has enormous potential for future growth and the technical set-up leads me to believe that readers could see Massive Gains on Monday's trading session! I will be sending more updates over the weekend for now continue your research below:

DNDT Website: http://www.dndtechnologies.com/index.html

DNDT Chart: http://www.otcmarkets.com/stock/DNDT/chart

DNDT News: http://www.otcmarkets.com/stock/DNDT/news